新医改形势下药物经济学评价的伦理学思考  

Ethical Thinking on Pharmacoeconomics Evaluation Under the new Healthcare Reform

作　　者：杨晨[1,2] 黄海[2] 罗茂华[2] 

机构地区：[1]南方医科大学研究生学院,广东广州510515 [2]广州军区广州总医院,广东广州510010

出　　处：《中国医学伦理学》2013年第2期222-223,共2页Chinese Medical Ethics

基　　金：广东省药学会项目"器官捐献移植体系中肾移植受者应用免疫抑制剂的药物经济学分析"(编号:2013A20)资助

摘　　要：现代医学研究中新技术、新药物的发展日新月异,患者在享有医学进步带来的成果的同时,也承担着日益增长的医疗费用,过度医疗、不合理用药等不良现象带来的后果。从伦理学学的角度分析问题出现的原因,提出药物经济学研究中应遵循的若干伦理原则,即经济原则、人文关怀、效价原则、社会公正原则、诚信原则、探索原则。Nowadays, the new technologies and new drug development in modern medical research change everyday. The patient enjoy the fruits of medical progress, at the same time, also bear the increasing medical expenses, excessive medical treatment, and the consequences of adverse phenomena such as the rational use of drugs. From the perspective of ethics, analyse the causes of the problems, put forward some ethical principles that should be followed in medical economics research, namely, economic principle, humanistic care, potency principle, the principle of social justice, the good faith principle, the principle of exploration.

关 键 词：药学伦理 药物经济学 合理用药 人文关怀 社会公正 

分 类 号：R-052[医药卫生]